Objective: Pro-inflammatory cytokines depress myocardial contractile function by enhancing peroxynitrite production, yet the mechanism by which peroxynitrite does this is unknown. As matrix metalloproteinases (MMPs) can be activated by peroxynitrite and can proteolytically cleave troponin I in hearts, we determined whether this occurs in cytokine-induced myocardial dysfunction. Methods: Isolated working rat hearts were perfused with buffer containing interleukin-1b, interferon-g, and tumor necrosis factor-a. Results: Cytokines induced a marked decline in mechanical function during 60-120 min of perfusion. This decline was accompanied by increased myocardial inducible NO synthase activity and perfusate dityrosine (a marker of peroxynitrite), compared to control hearts. Before the decline in mechanical function there was enhanced MMP-2 activity in the perfusate. This was accompanied by decreased tissue levels of MMP-2, tissue inhibitor of matrix metalloproteinases-4 and troponin I in cytokine-treated hearts. The collagen content of the heart was not affected by cytokine treatment. A neutralizing anti-MMP-2 antibody or the MMP inhibitors Ro31-9790 or PD166793 attenuated the decline in myocardial function. Moreover, the MMP-2 antibody prevented the decline in myocardial MMP-2 and troponin I levels. Conclusions: Myocardial contractile dysfunction caused by pro-inflammatory cytokines results in MMP-2 activation and a decline in tissue inhibitor of matrix metalloproteinases-4 in the heart. Troponin I is also a target for the proteolytic action of MMP-2 during acute heart failure triggered by pro-inflammatory cytokines. Inhibition of MMPs may be a novel pharmacological strategy for the treatment of acute inflammatory heart disease.
ynitrite is acutely enhanced during reperfusion of the containing 11 mM glucose, 5 mM pyruvate, 100 mU / ml 21 ischemic heart and contributes to myocardial stunning insulin, 1.75 mM Ca , 0.5 mM EDTA, 0.1% bovine injury [2, 3] . More recently, we demonstrated that peroxserum albumin, and 0.3 mM L-tyrosine as described ynitrite is a major contributor to pro-inflammatory cyto-(without pulmonary artery cannulation) [17] . Cardiac work kine-induced myocardial dysfunction by concerted en-(cardiac output3peak systolic pressure) was used as an hancement in both superoxide and NO generating activities index of mechanical function. After 20 min of equilibrain the heart [4] . Peroxynitrite can react and modify various tion in the working mode, hearts were perfused for 120 biological molecules such as proteins, thiols, lipids, and min in the absence (Control, n57) or presence of 5 ng / ml nucleic acids [5] . Indeed, peroxynitrite was shown to be a human IL-1b, 9 ng / ml rat IFN-g, and 20 ng / ml human potent activator of pro-MMPs without proteolytic removal TNF-a (Cytokines, n510) which was added as a bolus to of the propeptide domain, including pro-MMP-1 [6] , prothe perfusion buffer at t50 min. This mixture of pro-MMP-8 [6] , pro-MMP-9 [6] and pro-MMP-2 [7] . Meaninflammatory cytokines mimics those measured in the while, peroxynitrite may also alter the structural and systemic inflammatory response and advanced heart failure binding characteristics of endogenous tissue inhibitors of syndromes, enhances myocardial peroxynitrite generation MMPs (TIMPs), thus inhibiting their ability to prevent and causes a rapid loss in myocardial contractile function MMP activation [8] . This imbalance between MMPs and within 1-2 h of perfusion [4] . Perfusate samples were TIMPs favors the activation of MMPs and a proteolytic taken at 21, 1, 30, 60, 90, and 120 min to determine MMP environment within the cell. The upregulation of MMP activities and dityrosine levels. The ventricles were frozen activity and downregulation of TIMP action has been after 120 min of perfusion and processed as described [16] . shown to occur in pathological alterations of myocardial Additional series of hearts were perfused in the presence of ischemia [9] , infarct [10] and dilated cardiomyopathies cytokines for 120 min either with MMP inhibitors (Ro31- [11, 12] . The mechanism by which these changes occur 9790, 3 mM; PD166793, 2 mM), DMSO vehicle (0.3% during these processes are, however, not well known.
v:v), a peptide generated, neutralizing MMP-2 antibody Changes in MMP activity or expression that affect (30 mg / ml) or unrelated IgG (30 mg / ml). The specificity matrix remodeling are normally thought to occur on the and neutralizing activity of the MMP-2 antibody was time scale of hours to days. However, there is increasing previously determined [18] . PD166793 has the following evidence that MMPs can also very rapidly regulate diverse reported nM IC values (in parentheses) for MMP-1 50 cellular functions within minutes, including platelet aggre-(6100), MMP-2 (47), MMP-3 (12), MMP-7 (8100) and gation [13] , vascular tone [14] and modulation of the MMP-9 (9900) [19] , whereas for Ro31-9790 they are inflammatory response [15] , independent of their effects on MMP-1 (3), MMP-2 (7) and MMP-9 (12) [20] . Another the extracellular matrix. Recently we discovered that in set of hearts was briefly perfused for 15 min with Krebscardiac myocytes MMP-2 co-localizes with troponin I Henseleit buffer at a constant hydrostatic pressure of 70 (TnI), a regulatory element of the actin-myosin contractile mmHg to allow for the washout of blood in order to apparatus, and that it is susceptible to TnI proteolytic measure TnI content. degradation by MMP-2 [16] . During acute ischemia-reperfusion injury of the heart the proteolytic degradation of 2 .2. Preparation of heart extracts TnI by MMP-2 and mechanical dysfunction were prevented by inhibiting MMP activity [16] . Therefore, this For zymography and Western blot experiments, the study was designed to investigate whether there is an acute frozen ventricular tissue was powdered with a pestle and role of MMPs in the heart in the setting of pro-inflammamortar cooled to the temperature of liquid N and then 2 tory cytokine-induced myocardial dysfunction. homogenized by sonication in 50 mM Tris-HCl (pH 7.4) containing 3.1 mM sucrose, 1 mM DTT, 10 mg / ml leupeptin, 10 mg / ml soybean trypsin inhibitor, 2 mg / ml 2 . Methods aprotinin, and 0.1% Triton X-100. or repeated measures) ANOVA were used. Differences were considered significant at P,0.05.
.5. Measurement of MMPs by zymography
Gelatin zymography was performed as described [18] .
3 . Results Briefly, perfusate samples or heart extracts (20 mg protein) were applied to 7.5% polyacrylamide gel copolymerized Fig. 1A shows the time course of changes in cardiac with 2 mg / ml gelatin. After electrophoresis, gels were function, measured as cardiac work, in control and cytorinsed three times for 20 min each in 2.5% Triton X-100 in kine-treated hearts. Cardiac work in control hearts reorder to remove SDS. Then the gels were washed twice in mained stable for the 120 min of perfusion, while cytoincubation buffer (50 mM Tris-HCl, 5 mM CaCl , 150 kine-treated hearts showed a significant loss in cardiac 2 mM NaCl and 0.05% NaN ) for 20 min each at room work between 60 and 120 min of perfusion. Neutralizing 3 temperature and then incubated in incubation buffer at 37 8C for either 18 or 48 h for the perfusate and heart extract samples, respectively. The gels were stained in 2% Coomassie Brilliant blue G, 25% methanol, 10% acetic acid for 2 h and then destained for 1 h in 2% methanol-4% acetic acid. Zymograms were scanned and the band intensities were analyzed using Sigmagel software. MMP activities were expressed as a percentage of the MMP-2 standard (HT 1080 cell conditioned medium).
.6. Western blot analyses
The heart extract was diluted with protein sample buffer (30% v / v glycerol, 2% w / v SDS, 0.13 M Tris, 0.1 mg / ml bromphenol blue, and 4% v / v mercaptoethanol, pH 6.8), boiled for 5 min and then stored at 220 8C until assay. Then, 1 or 20 mg protein was applied to 12% polyacrylamide gels and electrophoresed under reducing conditions. After electrophoresis, samples were electroblotted onto polyvinylidene membranes (Bio-Rad Laboratories, Hercules, CA, USA) and probed for TIMP-4 (polyclonal anti-rat TIMP-4 antibody, Chemicon, Temecula, CA, USA) or for TnI (anti-human TnI antibody, clone 81-7; Spectral Diagnostics, Toronto, Canada).
.7. Collagen content
The collagen content in heart tissue was determined by mass spectrometric analysis for 4-hydroxyproline [21] . The anti-MMP-2 antibody [18] but not unrelated IgG prevented enhanced release of 72 kDa activity into the coronary the cytokine-induced loss of cardiac work (Fig. 1B) .
effluent there was a significant decrease in its content in Fig. 2A shows that the isolated working rat heart heart tissue (by 44%) at the end of perfusion and this continuously releases MMP-2 into the recirculating perfudecrease was attenuated in hearts treated with anti MMP-2 sate. Gelatinolytic activities were detected in the zymogantibody ( Fig. 3A and B ). rams at 75, 72, and 62 kDa corresponding to a rodentThe MMP inhibitors Ro31-9790 (0.01-3 mM) and specific glycosylated MMP-2 (Chris Overall, University of PD166793 (0.2-20 mM) concentration-dependently inBritish Columbia, personal communication), pro-MMP-2 hibited the 72-kDa gelatinolytic activity of perfusate and MMP-2, respectively, by comparison with the human samples taken from aerobically perfused hearts (data not HT1080 cell-derived standard. The 72-kDa activity constishown). We also tested their effects on cytokine-induced tuted the major gelatinase activity. In perfusate from changes in cardiac work. Ro31-9790 (3 mM), PD166793 control hearts there is a time-dependent accumulation of 72 (2 mM), and anti-MMP-2 antibody (30 mg / ml) attenuated kDa activity within the first hour of perfusion. Addition of the cytokine-induced loss in cardiac work as measured at cytokines markedly increased perfusate 72 kDa activity 120 min of perfusion (Fig. 4) . The vehicle for both MMP especially in the first 60 min of perfusion ( Fig. 2B and C) .
inhibitors was without effect (Fig. 4) . This preceded the onset of the delayed depression in
Since the balance between MMPs and TIMPs might be cardiac work, which was first significantly impaired in the altered in an inflammatory environment, and TIMP-4 is a cytokine group at 90 min perfusion (Fig. 1A) . There was a potent inhibitor of MMP-2 [22] and abundantly expressed similar increase in 64 kDa activity in the perfusate from in the heart [23] , we then determined myocardial TIMP-4 cytokine treated hearts, however, this was not within a levels. TIMP-4 was detected in control hearts and its level quantifiable range (data not shown). Concomitant with the was significantly decreased by 54% in cytokine-treated hearts (Fig. 5 ).
To evaluate whether the extracellular matrix of the heart was affected in response to cytokines we measured total collagen by determining 4-hydroxyproline content. In control, cytokine and cytokine plus anti-MMP-2 antibody groups the amount of 4-hydroxyproline was not significantly different (0.5860.10, 0.6660.07 and 0.6560.08 mg / mg dry tissue weight, respectively). gelatinolytic activity in all heart tissue samples. * P,0.05 versus control * P,0.05 (two-way repeated measures ANOVA).
(one-way ANOVA, n57-10 per group).
the mechanical dysfunction of the heart following ischemia-reperfusion injury [16] . We therefore measured the level of TnI as a target for the action of MMP-2 in the 2-h perfused heart groups ( Fig. 6) . In cytokine treated hearts there was a dramatic reduction in the level of 31 kDa TnI compared to control. Addition of either anti-MMP-2 antibody or the MMP inhibitor PD 166793 to the cytokine treated hearts prevented the loss in TnI content. Indeed the level of TnI in cytokine plus anti-MMP-2 antibody treated hearts was significantly higher than in control hearts. As a 2-h period of isolated working heart perfusion per se is a mild oxidative stress [17] , we therefore analyzed an additional set of hearts perfused aerobically for only 15 min in vitro to wash them free of blood. Indeed the level of TnI in these hearts was comparable to the 2-h isolated working hearts perfused with cytokines plus the anti- were upregulated in the heart by pro-inflammatory cytokines [4], we measured NO synthase activities in some We recently showed that there is intracellular co-localihearts and perfusate dityrosine levels. In ventricular tissue 21 zation of MMP-2 with troponin I (TnI), the regulatory from hearts perfused for 120 min, the Ca -dependent NO element of contractile proteins within the sarcomere of the synthase activity (between 1-2 pmol / min / mg protein) was cardiac myocyte [16] . We also found that TnI is susceptible to proteolytic degradation by MMP-2 which contributes to hearts per group). * P,0.05 versus control (one-way ANOVA).
MMP-2 activity and the level of its endogenous inhibitor TIMP-4 in heart tissue were reduced in cytokine-treated hearts. The collagen content of the heart was unaltered by cytokine treatment, however, the level of TnI was diminished. Pharmacological inhibitors of MMP or a neutralizing MMP-2 antibody protected the heart from the loss in TnI as well as the myocardial dysfunction caused by cytokines.
We have recently shown using this model of acute myocardial contractile dysfunction that pro-inflammatory cytokines enhance the myocardial generation of the prooxidant species peroxynitrite through an enhancement in both superoxide and NO generating enzyme activities, which are together responsible for the depression in contractile function [4] . This was confirmed in the present study with the enhanced inducible NO synthase activity in heart tissue and perfusate dityrosine level, an indicator of peroxynitrite generation [2,4]. We also recently found that the activation and release of MMP-2 from the heart contributes to another oxidant stress induced injury to the heart caused by ischemia and reperfusion [18] . The oxidant stress of acute myocardial ischemia-reperfusion injury is also mediated by the generation of peroxynitrite [2,3]. As MMPs can be activated by oxidant stress, we determined here whether cytokine-induced cardiac dysfunction is also mediated through MMPs.
In accordance with our previous report [18] , the main gelatinolytic activity in coronary effluent from the aerobically perfused heart is 72 kDa, corresponding to pro-MMP-2. A rapid and significant increase in 72 kDa activity 21 21 was observed within the first hour in the perfusate from in the catalytic centre [24] , which then exposes the catalytic site followed by proteolytic activation, or through not significantly different between control and cytokineoxidant-induced conformational changes [6] . Previous treated hearts (Fig. 7A) . In contrast, cytokine treatment studies suggested oxygen free radicals may be capable of 21 resulted in a near seven-fold increase in Ca -independent activating matrix metalloproteinases in perfused rat hearts activity, which was not abolished by anti-MMP-2 anti- [25] . Indeed, the powerful oxidant peroxynitrite can acti- 21 body. In accordance with the increase in Ca -independent vate pro-MMP-2 in human smooth muscle cells [7] and NOS activity, the level of perfusate dityrosine (a marker 1-20 mM peroxynitrite activated purified pro-MMPs withfor peroxynitrite) in cytokine treated hearts showed a out a change in molecular weight [6] . Recently we have time-dependent increase which was statistically significant shown that the acute mechanical dysfunction caused by the at 90 and 120 min (Fig. 7B) .
infusion of peroxynitrite into the heart is mediated through MMP-2 [26] . It is therefore more accurate to specify the MMP-2 activities reported here by molecular weight than 4 . Discussion by the use of the designations 'pro-MMP-2' and 'MMP-2' which imply inactive and active forms of the enzyme, We show here for the first time that pro-inflammatory respectively, when this indeed may not be the case. cytokines cause a rapid and enhanced release of MMP-2
Endogenous tissue inhibitors of metalloproteinases activity from the heart into the perfusate. This preceded the (TIMPs) also control MMP activity. Interestingly, peroxonset of a marked depression in cardiac mechanical ynitrite was shown to inactivate TIMP-1 in vitro [8] . We function. At the end of perfusion both the remaining chose to investigate TIMP-4 as it is the most abundantly expressed TIMP in heart tissue compared with other matrix. An intracellular association of MMP-2 with the organs [23] and is found in both human [23] and murine sarcolemma was found in hearts from patients with dilated hearts [27] . Moreover, it has been demonstrated that cardiomyopathy [34] . This indicates that elements of the TIMP-4, unlike TIMP-2, does not promote but actually contractile apparatus may represent a molecular target for inhibits the activation of MMP-2 [22] . There was also a the detrimental actions of MMP-2. We recently showed decrease in TIMP-4 levels resulting from the exposure of that the contractile protein regulatory element TnI is the heart to cytokines. It is interesting to speculate that this susceptible to rapid proteolytic cleavage by MMP-2 and loss in TIMP-4 protein also contributed to enhanced MMP that inhibition of MMP activity prevents TnI degradation activity and the depression in myocardial function.
while improving the recovery of mechanical function in Our results provide compelling evidence that MMP-2 ischemic-reperfused hearts [16] . Moreover several lines of acts as a mediator to cytokine-induced myocardial evidence showed the co-localization of MMP-2 with TnI in dysfunction. Several observations support this: (1) cytocardiac myocytes [16] . Indeed, results from the present kine-treated hearts showed a significant loss in cardiac experiments show that cytokine treatment caused a marked work between 60 and 120 min of perfusion, (2) this was loss in myocardial TnI content which was prevented by the preceded by a rapid and marked increase of MMP-2 neutralizing anti-MMP-2 antibody. This provides further activity in perfusate, (3) this occurred in conjunction with evidence for the intracellular action of MMP-2 and that a decrease of MMP-2 and TIMP-4 in heart tissue following TnI is a target for MMP-2 in the setting of cytokinecytokine treatment, and (4) Ro31-9790 and PD166793, induced myocardial depression. Recently, several other inhibitors of MMP activity, prevented and a neutralizing novel substrates and resulting biological activities of MMP-2 antibody abolished the depression in mechanical MMP-2, independent of its well-described activities on the function. The MMP-2 antibody, however, did not affect extracellular matrix, have been described. This includes the cytokine-induced increase in inducible NO synthase roles for MMP-2 in the control of vascular tone [14] , activity, excluding the possibility that it nonspecifically platelet aggregation [13] , and inflammation [15] suggesting inactivated cytokines or interfered with the expression of that this protease can have effects on a more rapid time inducible NO synthase.
scale and with both intracellular and extracellular loci of In accordance with our findings, activation of MMPs is action. implicated in cardiac injury resulting from diverse
In summary, we have demonstrated that pro-inflammapathologic insults such as ischemia, infarction, and inflamtory cytokines induced depression of mechanical function mation. Cheung et al. [18] found in isolated rat hearts that of the heart is mediated by MMP-2. Inhibition of MMP MMP-2 was rapidly released into the perfusate during the activity protects the heart from cytokine-induced myocarfirst minute of reperfusion after ischemia. Inhibitors of dial injury, thus MMP-2 may be a viable target for the MMP or a neutralizing anti-MMP-2 antibody improved the therapeutic intervention of inflammatory heart disease. recovery of post-ischemic mechanical function [18] . Li et al. [12] demonstrated a selective downregulation of both TIMP-1 and -3 transcripts and proteins along with upregu-A cknowledgements lation of myocardial MMP-9 gelatinolytic activity in cardiomyopathic ventricles. Much evidence supports that
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